StreetInsider.com News Articles

Form ARS NEUROONE MEDICAL TECHNOL For: Sep 30

Mon, 09 Mar 2026 08:02:00 -0400

si-local-file:///var/storage/secattach/20260309/26129213.html

Form ARS NEUROONE MEDICAL TECHNOL For: Sep 30

Mon, 09 Mar 2026 08:02:00 -0400

si-local-file:///var/storage/secattach/20260309/26129213.html

Form DEF 14A NEUROONE MEDICAL TECHNOL For: Apr 03

Mon, 09 Mar 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260309/26129193.html

Form DEF 14A NEUROONE MEDICAL TECHNOL For: Apr 03

Mon, 09 Mar 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260309/26129193.html

Form 4 NEUROONE MEDICAL TECHNOL For: Mar 01 Filed by: Wambeke David J.

Tue, 03 Mar 2026 08:49:00 -0400

si-local-file:///var/storage/secattach/20260303/26097359.html

Form 4 NEUROONE MEDICAL TECHNOL For: Mar 01 Filed by: Wambeke David J.

Tue, 03 Mar 2026 08:49:00 -0400

si-local-file:///var/storage/secattach/20260303/26097359.html

Form 3 NEUROONE MEDICAL TECHNOL For: Mar 01 Filed by: Wambeke David J.

Tue, 03 Mar 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260303/26097281.html

Form 3 NEUROONE MEDICAL TECHNOL For: Mar 01 Filed by: Wambeke David J.

Tue, 03 Mar 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260303/26097281.html

Jones Trading Starts Neuroone Medical Technologies (NMTC) at Buy

Mon, 02 Mar 2026 07:18:32 -0400

Jones Trading analyst Justin Walsh initiates coverage on Neuroone Medical Technologies (NASDAQ: NMTC) with a Buy rating and a price target of $1.50.

The analyst comments "Summary. We are initiating coverage of NeuroOne Technologies Corporation (NMTC) with a Buy rating and $1.50 price target. NeuroOne is a commercial medtech company with a portfolio of four FDA-cleared products for the monitoring, recording, stimulation, and ablation of nervous tissue. With support from distribution partner Zimmer Biomet Holdings (ZBH, Not Rated), the company grew product revenue from $3.5M in FY24 to $9.1M in FY25, driven by sales of its OneRF Ablation System. Given that

Jones Trading Starts Neuroone Medical Technologies (NMTC) at Buy

Mon, 02 Mar 2026 07:18:32 -0400

Jones Trading analyst Justin Walsh initiates coverage on Neuroone Medical Technologies (NASDAQ: NMTC) with a Buy rating and a price target of $1.50.

Form PRE 14A NEUROONE MEDICAL TECHNOL For: Apr 03

Fri, 27 Feb 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260227/26082591.html

Form PRE 14A NEUROONE MEDICAL TECHNOL For: Apr 03

Fri, 27 Feb 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260227/26082591.html

Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 25

Wed, 25 Feb 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260225/26060677.html

Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 25

Wed, 25 Feb 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260225/26060677.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Mertens Steve

Fri, 20 Feb 2026 14:28:00 -0400

si-local-file:///var/storage/secattach/20260220/26035350.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Mertens Steve

Fri, 20 Feb 2026 14:28:00 -0400

si-local-file:///var/storage/secattach/20260220/26035350.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Christianson Mark

Fri, 20 Feb 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260220/26035329.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Christianson Mark

Fri, 20 Feb 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260220/26035329.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Rosa David A

Fri, 20 Feb 2026 14:15:00 -0400

si-local-file:///var/storage/secattach/20260220/26035302.html

Form 4 NEUROONE MEDICAL TECHNOL For: Feb 18 Filed by: Rosa David A

Fri, 20 Feb 2026 14:15:00 -0400

si-local-file:///var/storage/secattach/20260220/26035302.html

Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 17

Tue, 17 Feb 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260217/26006647.html

Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 17

Tue, 17 Feb 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260217/26006647.html

Form 10-Q NEUROONE MEDICAL TECHNOL For: Dec 31

Tue, 17 Feb 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260217/26005816.html

Form 10-Q NEUROONE MEDICAL TECHNOL For: Dec 31

Tue, 17 Feb 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260217/26005816.html

NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time

Wed, 04 Feb 2026 16:30:00 -0400

EDEN PRAIRIE, MINN. - February 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2025, before market open on February 17, 2026.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Tuesday, February 17, 2026, to discuss the Companys first quarter fiscal year 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the